Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ze Xiao

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 28, 2012
An optimized antiviral modification strategy for prevention of hepatitis B reactivation in patients undergoing prophylactic lamivudine and chemotherapy: a pilot studyXiang-Yuan Wu, Xing Li, Zhan-Hong Chen, et al.
Oncology Letters|November 9, 2017
Serum Golgi protein 73 is a prognostic rather than diagnostic marker in hepatocellular carcinomaMin Dong, Zhan-Hong Chen, Xing Li, et al.
Ebiomedicine|October 31, 2021
Retraction notice to "LSAMP-AS1 binds to microRNA-183-5p to suppress the progression of prostate cancer by up-regulating the tumor suppressor DCN" [eBioMedicine 50 (2019) 178 - 190]Xing Hua, Zhen Liu, Min Zhou, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 23, 2016
Erratum to: Neutrophil-to-lymphocyte ratio acts as a prognostic factor for patients with advanced hepatocellular carcinomaXing Li, Zhan-Hong Chen, Xiao-Kun Ma, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|January 9, 2016
Efficacy of Prophylactic Entecavir for Hepatitis B Virus-Related Hepatocellular Carcinoma Receiving Transcatheter Arterial ChemoembolizationXing Li, Xiang Zhong, Zhan-Hong Chen, et al.
Oncology Reports|July 15, 2014
Aberrant expression of enhancer of zeste homologue 2, correlated with HIF-1α, refines relapse risk and predicts poor outcome for breast cancerMin Dong, Xin-Juan Fan, Zhan-Hong Chen, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 7, 2014
Neutrophil-to-lymphocyte ratio acts as a prognostic factor for patients with advanced hepatocellular carcinomaXing Li, Zhan-Hong Chen, Xiao-Kun Ma, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|December 19, 2014
Hepatitis B virus DNA negativity acts as a favorable prognostic factor in hepatocellular carcinoma patientsXing Li, Xiang Zhong, Zhan-Hong Chen, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 13, 2015
Comparison of five models for end-stage liver disease in predicting the survival rate of patients with advanced hepatocellular carcinomaYing-Fen Hong, Zhan-Hong Chen, Xiao-Kun Ma, et al.
Oncology Letters|July 12, 2017
Validation and ranking of seven staging systems of hepatocellular carcinomaZhan-Hong Chen, Ying-Fen Hong, Jinxiang Lin, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 28, 2012
An optimized antiviral modification strategy for prevention of hepatitis B reactivation in patients undergoing prophylactic lamivudine and chemotherapy: a pilot studyXiang-Yuan Wu, Xing Li, Zhan-Hong Chen, et al.
Oncology Letters|November 9, 2017
Serum Golgi protein 73 is a prognostic rather than diagnostic marker in hepatocellular carcinomaMin Dong, Zhan-Hong Chen, Xing Li, et al.
Ebiomedicine|October 31, 2021
Retraction notice to "LSAMP-AS1 binds to microRNA-183-5p to suppress the progression of prostate cancer by up-regulating the tumor suppressor DCN" [eBioMedicine 50 (2019) 178 - 190]Xing Hua, Zhen Liu, Min Zhou, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 23, 2016
Erratum to: Neutrophil-to-lymphocyte ratio acts as a prognostic factor for patients with advanced hepatocellular carcinomaXing Li, Zhan-Hong Chen, Xiao-Kun Ma, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|January 9, 2016
Efficacy of Prophylactic Entecavir for Hepatitis B Virus-Related Hepatocellular Carcinoma Receiving Transcatheter Arterial ChemoembolizationXing Li, Xiang Zhong, Zhan-Hong Chen, et al.
Oncology Reports|July 15, 2014
Aberrant expression of enhancer of zeste homologue 2, correlated with HIF-1α, refines relapse risk and predicts poor outcome for breast cancerMin Dong, Xin-Juan Fan, Zhan-Hong Chen, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 7, 2014
Neutrophil-to-lymphocyte ratio acts as a prognostic factor for patients with advanced hepatocellular carcinomaXing Li, Zhan-Hong Chen, Xiao-Kun Ma, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|December 19, 2014
Hepatitis B virus DNA negativity acts as a favorable prognostic factor in hepatocellular carcinoma patientsXing Li, Xiang Zhong, Zhan-Hong Chen, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 13, 2015
Comparison of five models for end-stage liver disease in predicting the survival rate of patients with advanced hepatocellular carcinomaYing-Fen Hong, Zhan-Hong Chen, Xiao-Kun Ma, et al.
Oncology Letters|July 12, 2017
Validation and ranking of seven staging systems of hepatocellular carcinomaZhan-Hong Chen, Ying-Fen Hong, Jinxiang Lin, et al.
Pageof 8